This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Community Health (CYH) Unit Offers Notes $2.8B in Two Tranches
by Zacks Equity Research
Community Health's (CYH) wholly-owned arm exhibits monetary discretion by issuing notes to procure funds.
Tenet Healthcare (THC) to Buy 45 Ambulatory Surgery Centers
by Zacks Equity Research
Tenet Healthcare (THC) to purchase 45 ambulatory surgery centers to aid its USPI ambulatory business, thus bolstering its position as a national musculoskeletal services leader in healthcare.
Acadia Healthcare (ACHC) Up 54% in 6 Months: More Room to Run?
by Zacks Equity Research
Acadia Healthcare (ACHC) gains on the back of rising demand for its behavioral healthcare services, business rejig, cost-controlling efforts and strong cash flows.
Is HCA Healthcare (HCA) a Profitable Stock to Pick Now?
by Zacks Equity Research
Is HCA Healthcare (HCA) a great pick from the value investor's perspective right now? Read on to know more.
Why Is HCA (HCA) Up 18.8% Since Last Earnings Report?
by Zacks Equity Research
HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ensign Group (ENSG) Up 57.2% Year to Date: More Room for Rally?
by Zacks Equity Research
Ensign Group's (ENSG) strategic measures along with a solid capital position are likely to fetch revenues, which in turn, may perk up its share price.
Community Health (CYH) Soars 168.6% YTD: More Room to Run?
by Zacks Equity Research
Community Health's (CYH) strategic measures along with the surge in telehealth visits are likely to fetch revenues, which in turn, may bump up its share price.
Reasons to Add Acadia Healthcare (ACHC) to Your Portfolio
by Zacks Equity Research
Better-than-expected Q3 results, positive estimate revisions, high demand for services, bed expansion, business streamlining make Acadia Healthcare (ACHC) an attractive investment bet.
4 Sector ETFs & Stocks to Buy on Forecast-Beating Jobs Data
by Sanghamitra Saha
The U.S. economy added 638,000 jobs in October 2020, easing from an upwardly revised 672,000 in the previous month.
Wining & Losing Sector ETFs Post Election Day
by Sanghamitra Saha
Chances of a dividend congress caused a superb rally in Wall Street the day after election.
Humana's (HUM) Q3 Earnings Surpass Estimates, Decline Y/Y
by Zacks Equity Research
Humana's (HUM) third-quarter earnings reflect improved revenues, partly offset by expenses.
Select Medical's (SEM) Q3 Earnings Beat Mark, Improve Y/Y
by Zacks Equity Research
Select Medical's (SEM) third-quarter 2020 earnings gain traction from better revenues at its Critical Illness Recovery and Rehabilitation Hospital segments.
Universal Health's (UHS) Q3 Earnings Surpass, Improve Y/Y
by Zacks Equity Research
Universal Health's (UHS) third-quarter results reflect higher revenues and lower expenses.
Ensign Group's (ENSG) Q3 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q3 results reflect healthy revenues and its robust Transitional and Skilled Services segment.
Molina Healthcare's (MOH) Q3 Earnings Beat, Increase Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter results reflect higher revenues and membership.
Community Health's (CYH) Earnings Beat in Q3, Improve Y/Y
by Zacks Equity Research
Community Health's (CYH) third-quarter earnings gain from lower costs. However, the same is offset to some extent due to soft admissions.
Anthem (ANTM) Q3 Earnings Surpass Estimates, Decline Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q3 earnings benefit from strong Medicaid and Medicare businesses as well as solid contributions from its Commercial & Specialty Business and Government Business.
Company News for Oct 27, 2020
by Zacks Equity Research
Companies In The News Are: HCA, SAP, NRZ, CBU.
HCA Healthcare (HCA) Q3 Earnings Miss Estimates, Down Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter results reflect decline in admissions, partly offset by higher revenues.
HCA Holdings (HCA) Q3 Earnings Lag Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of -28.62% and 0.04%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
HCA Healthcare (HCA) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter 2020 results are likely to reflect higher revenues owing to the gradual rise in patient volumes following the easing of government restrictions.
Here's Why You Should Retain Universal Health (UHS) for Now
by Zacks Equity Research
Riding high on its solvency position, strong segments and strategic initiatives, Universal Health (UHS) holds potential to reap benefits.
Here's Why You Should Retain Tenet Healthcare (THC) Stock
by Zacks Equity Research
Riding high on its strategic measures and cost-cutting methods, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.
A Volatile Week Ends with Stocks Broadly Higher
by David Borun
Stimulus talks grind on, but equity investors seem to be pricing in a big package.
HCA Healthcare (HCA) Announces Preliminary Results for Q3
by Zacks Equity Research
HCA Healthcare (HCA) reports preliminary results for the third quarter of 2020. Final results will be released on or around Oct 26.